Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Biomedicines|August 29, 2024
NK Cells in the Lymph Nodes and Their Role in Anti-Tumour ImmunityLara V Graham, Salim I Khakoo, Matthew D BluntJournal of Translational Genetics and Genomics|January 17, 2024
Targeting KIR as a novel approach to improve CAR-NK cell functionLara V Graham, Jack G Fisher, Salim I Khakoo, et al.Vaccines|December 23, 2022
Disruption of the NKG2A:HLA-E Immune Checkpoint Axis to Enhance NK Cell Activation against CancerJack G Fisher, Amber D P Doyle, Lara V Graham, et al.Clinical and Experimental Immunology|January 13, 2026
CD40L and IL-4 Lymph Node-Associated Signals Protect B Cells from Rituximab-Induced ADCC via KIR and NKG2ALara V Graham, Russell B Foxall, Margaret Ashton-Key, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 29, 2022
KIR2DS2 Expression Identifies NK Cells With Enhanced Anticancer ActivityMatthew D Blunt, Andres Vallejo Pulido, Jack G Fisher, et al.Leukemia|August 1, 2023
XPO1 inhibition sensitises CLL cells to NK cell mediated cytotoxicity and overcomes HLA-E expressionJack G Fisher, Amber D P Doyle, Lara V Graham, et al.Frontiers in Oncology|September 17, 2024
KIR2DS2+ NK cells in cancer patients demonstrate high activation in response to tumour-targeting antibodiesLara V Graham, Jack G Fisher, Amber D P Doyle, et al.Science Advances|August 23, 2024
The nuclear export protein XPO1 provides a peptide ligand for natural killer cellsMatthew D Blunt, Hayden Fisher, Ralf B Schittenhelm, et al.Immunotherapy Advances|September 22, 2025
CD40L and IL-4 suppress NK cell-mediated antibody-dependent cellular cytotoxicity through the HLA-E:NKG2A axisLara V Graham, Ludmila Horehajova, Marco V Haselager, et al.Pageof 1